Here you can find all the latest news from the MRC CTU at UCL.
Easy-to-take medicine better at suppressing HIV in children
Adding abiraterone to standard therapy helps men with high-risk localised prostate cancer to live longer
Handbook on Monitoring of clinical trials launched
UCL-TB to host WHO drug-resistant TB database
Quality of life better in men taking abiraterone rather than docetaxel for hormone-sensitive prostate cancer